Fibromyalgia: Biological correlates

Current Opinion in Psychiatry

Volumn 13, Issue 6, 2000, Pages 623-628

  Richards, Selwyn ^a   Cleare, Anthony J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MELATONIN;

AUTOIMMUNITY; DISEASE ASSOCIATION; FIBROMYALGIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOLECULAR GENETICS; MUSCULOSKELETAL SYSTEM; NEUROCHEMISTRY; PREVALENCE; REVIEW; SLEEP;

EID: 0033769131     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200011000-00026     Document Type: Review

References (51)

1. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee
2. Factors associated with fatigue in patients with systemic lupus erythematosus
3. 'Silicone related symptoms' are common in patients with fibromyalgia: No evidence for a new disease
4. Silicone filled breast implants and the risk of fibromyalgia and rheumatoid arthritis
5. Gulf War illnesses: Causation and treatment
6. Musculoskeletal manifestations, pain, and quality of life in Persian Gulf War veterans referred for rheumatologic evaluation
7. Prevalence of fibromyalgia in children: A clinical study of Mexican children
8. The London Fibromyalgia Epidemiology Study: The prevalence of fibromyalgia syndrome in London, Ontario
9. The London Fibromyalgia Epidemiology Study: Direct health care costs of fibromyalgia syndrome in London, Canada
10. The association between chronic widespread pain and mental disorder: A population-based study
11. A prospective study of tender points and fibromyalgia during and after an acute viral infection
12. Fibromyalgia in lupus erythematosus
13. Association of coping responses with fibromyalgia tender points in patients with systemic lupus erythematosus
14. Quality of life in systemic lupus erythematosus: A controlled study
15. Fibromyalgia in inflammatory bowel disease
16. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia
17. Changes in platelet alpha-2adrenoceptors in fibromyalgia: Effects of treatment with antidepressants
18. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients
19. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome
20. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity
21. Gulf War syndrome: Is it due to a systemic shift in cytokine balance towards a Th2 profile?
22. Chronic rhinitis: An underrecognized association with fibromyalgia
23. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: Cross sectional study
24. Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle
25. Muscle performance in fibromyalgia syndrome
26. Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women
27. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue
28. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia
29. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis
30. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia
31. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia
32. Fibromyalgia: Family clustering and sensory urgency with early onset indicate genetic predisposition and thus a 'true' disease
33. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia
34. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region
35. Genetic linkage analysis of multicase families with fibromyalgia syndrome
36. Fibromyalgia a syndrome associated with decreased nocturnal melatonin secretion
37. Normal melatonin levels in patients with fibromyalgia syndrome
38. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome
39. The effect of melatonin in patients with fibromyalgia A pilot study
40. A six month randomized double blind placebo controlled trial comparing melatonin to placebo in the treatment of fibromyalgia
41. Neuroendocrine abnormalities in fibromyalgia and related disorders
42. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome
43. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome
44. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
45. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain
46. The growth hormone (GH)releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome
47. A randomized, double-blind, placebocontrolled study of growth hormone in the treatment of fibromyalgia
48. Musculosketal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects
49. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation
50. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women
51. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia Preliminary report